GlassScriptPhysician profile
Julia Park
NPI 1730405788
$14,157.89
in general payments reported to CMS, 2019-2025
11 companies · $2,256 in 2025
The $2,256 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,531 · 2020: $710 · 2021: $1,918 · 2022: $2,006 · 2023: $2,007 · 2024: $2,730 · 2025: $2,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,612 · Consulting Fee: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,612.36 |
| Consulting Fee | $380.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,272.41 | 2021-2025 | Signia, Ligasure, Progrip |
| W. L. Gore & Associates, INC. | $3,974.86 | 2019-2024 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Allergan, INC. | $1,445.49 | 2021-2022 | |
| Davol INC. | $822.61 | 2023-2025 | Phasix Mesh, Arista, Arista Ah Flexitip |
| Abbvie INC. | $694.69 | 2023-2025 | |
| Covidien LP | $631.58 | 2019-2020 | |
| Olympus America INC. | $585.02 | 2022-2024 | Olympus, Olympus |
| Tela Bio, INC. | $312.13 | 2024 | Ovitex 2s |
| Becton, Dickinson and Company | $225.19 | 2024 | Phasix Mesh |
| Reshape Lifesciences INC. | $134.34 | 2023 | |
| Intuitive Surgical, INC. | $59.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.